Effects of an oral antidiabetic drug on the fibrinolytic system of blood in insulin-treated diabetic patients
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 37 (10) , 937-943
- https://doi.org/10.1016/0026-0495(88)90150-3
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- A simplified estimation of tissue plasminogen activator (t-PA) inhibition in human plasmaFibrinolysis, 1987
- A comparison of the determination of glucosylated haemoglobin by isoelectric focusing and cation-exchange chromatography on minicolumnsScandinavian Journal of Clinical and Laboratory Investigation, 1986
- Abnormal endothelial release of fibrinolytic activity and fibronectin in diabetic microangiopathyDiabetologia, 1984
- Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetesThrombosis Research, 1984
- Nonenzymatic Glycosylation Reduces the Susceptibility of Fibrin to Degradation by PlasminDiabetes, 1983
- THE PHENOMENON OF THE ACUTE PHASE RESPONSE*Annals of the New York Academy of Sciences, 1982
- The use of evacuated glass tubes for collection of blood samples for fibrinolytic assaysThrombosis Research, 1982
- A Study of the Conditions and Accuracy of the Thrombin Time Assay of Plasma FibrinogenActa Haematologica, 1982
- Haemostatic variables associated with diabetes and its complications.BMJ, 1979
- A plasminogen proactivator-activator system in human blood effective in absence of hageman factorThrombosis Research, 1974